Acquirer | Target | Price |
---|---|---|
Agilent Technologies Inc. | Seahorse Bioscience | $235 million |
Concordia Healthcare Corp. | Amdipharm Mercury Limited | $3.3 billion |
Eprirus Biopharmaceuticals, Inc. | Bioceros Holding B.V. | $14.1 million |
Biogen Inc. | License to MT-1303 | $60 million |
Apricus Biosciences, Inc. | U.S. rights to Vitaros™ | $1 million |